Medical Device Manufacturing · Sub-niche
Diagnostic & Laboratory Equipment Financing
Diagnostic and lab-equipment makers sell high-ticket instruments plus recurring reagent and consumable revenue. Equipment financing on the capital instrument side and factoring on reagent / consumable receivables let the razor-and-blade model actually scale.
Diagnostics is capital instrument plus recurring reagents — a classic razor-and-blade model. The instrument sale is lumpy and large; the reagent pull-through is steady but paid on 60–90 day terms.
The right funding stack fits both halves. Equipment financing (or lease structures where the end-lab prefers to lease from you) handles the instrument side. Factoring handles the reagent and consumable AR.
We work with lenders who understand IVD, CLIA-waived vs high-complexity, molecular diagnostics, and the CMS / hospital payor mix that drives reference-lab economics. Your recurring revenue is a strength — the right structure treats it that way.
Want a written answer specific to your diagnostic & laboratory equipment operation? Email a specialist — no pressure, no obligation, no fees to you.
What underwriters will actually ask for
Diagnostic & Laboratory Equipment files have a specific documentation pattern. Bringing these up front usually cuts weeks off the timeline.
FDA clearance / approval and CLIA categorization
510(k), PMA, or de novo clearance for the instrument, plus CLIA complexity categorization. CLIA-waived products open a broader buyer base than high-complexity.
ISO 13485 certificate and quality system documentation
Current ISO 13485 with IVD scope where applicable. Design history file and DMR are standard due diligence.
Instrument install base and reagent pull-through data
For revenue-based facilities and instrument lease structures, the ratio of instruments placed to recurring reagent revenue drives underwriting.
Aged AR split (instrument sales vs reagent / consumable)
Different DSO and different buyer types. Instrument invoices to hospitals or reference labs vs recurring reagent invoices to the same or related buyers.
Trailing 12-month financials and reagent-rental / referral model detail
Reagent rental (placed instrument, charge per test) creates a different revenue pattern than outright instrument sale. Lenders that understand the model structure it appropriately.
Equipment invoice or bill of materials (for equipment financing)
For your own capital equipment: injection presses, PCB assembly, cleanroom, optical assembly. Instruments you place at end-labs can also be financed as revenue-generating assets under a lease-back structure.
Programs diagnostic & laboratory equipment operators actually use
Ranked by how often they're the right fit for this sub-niche, with the reason each one works written for diagnostic & laboratory equipment specifically. Your actual match depends on buyers, margins, and the working capital problem you're solving.
Program
Equipment Financing
Why it fits here: Analyzers, optics, automation, and assembly equipment finance against the asset. Placed-instrument and reagent-rental models are familiar territory for lenders in this category.
See how it works →
Program
Invoice Factoring
Why it fits here: Invoices to labs, hospital systems, and distributors factor on the payor's credit. Reagent and consumable receivables factor alongside instrument sales.
See how it works →
Program
Working Capital
Why it fits here: Bridges the stretch between instrument referrals and the consumable revenue that follows, or a production ramp ahead of a confirmed distribution rollout.
See how it works →
Important disclosures for diagnostic & laboratory equipment
Sub-niche pages are informational. Manufactor Finance is an independent business financing referral service — not a bank, lender, direct funder, private equity firm, or investor, and not FDA, CMS, CLIA, or legal counsel. Nothing here is regulatory, reimbursement, or accounting advice on reagent-rental revenue recognition. Advance rates, program availability, and terms are set solely by the funding partner and vary by clearance type, buyer mix, and state of operation.
A location page on this site indicates that Manufactor Finance is taking clients in that market — it does not represent a physical office, storefront, or licensed presence in that city or state. All services are delivered remotely by our US-based specialists. Manufactor Finance is an independent business financing referral service, not a bank, lender, direct funder, private equity firm, or investor, and we do not make credit decisions.
Diagnostic & Laboratory Equipment financing by city
Local pages for every metro we serve, with the buyer mix and payment terms that shape the file.
Diagnostic & Laboratory Equipment financing — FAQs
Medtech-experienced lenders do. Reagent-rental creates a subscription-like recurring revenue stream against a placed instrument, which underwrites well for revenue-based facilities and can support a lease structure for the instrument side.
Yes, through a lease-back or sale-leaseback structure. You keep the customer relationship and reagent pull-through; the financing partner takes the instrument as collateral. Term matches the expected instrument life.
Similar but not identical. Large reference labs (Quest, Labcorp, BioReference) are strong credits and factor cleanly. Regional reference labs and academic labs get underwritten individually.
Molecular / NGS diagnostic manufacturers are a familiar category. Class II 510(k), PMA, or LDT-based products all fit; underwriting adjusts for reimbursement risk and clinical adoption stage.
Yes. Multi-instrument orders to hospital systems or reference-lab networks are strong PO financing candidates. Lead time on the components (optical, molecular, chemistry modules) drives the financing timeline.
CLIA-waived expands the addressable market to physician offices and point-of-care sites, which lenders view as a growth positive. High-complexity products serve reference labs and hospital cores with strong credit — also positive. Both fit; the market data changes.
Other medical device manufacturing sub-niches
FDA Class II Devices
Working capital and equipment financing for 510(k)-cleared Class II device manufacturers.
Contract Manufacturing (CMO / CDMO)
Financing for medical device and medtech contract manufacturers, CMOs, and CDMOs serving OEM brand owners.
Orthopedic & Implantable Devices
Financing for orthopedic implant, spine, trauma, and Class III implantable device manufacturers.
Sterile Packaging & Contract Sterilization
Equipment financing, working capital, and factoring for sterile barrier packagers and EO, gamma, or e-beam contract sterilization providers.
Single-Use Disposables & Procedure Kitting
Working capital, PO financing, and factoring for manufacturers of single-use disposables and custom procedure kits sold to hospitals and GPOs.
Funding Requirements Checklist for US manufacturers
See exactly what underwriters actually look at — for factoring, PO financing, equipment, working capital, ABL, and SBA — before you fill out a single application.
- What documents you need for each program
- Typical time-to-fund by program
- Common disqualifiers worth knowing up front
- How Manufactor Finance is compensated — $0 fees to you
Talk to a funding specialist
Questions before you apply? A specialist can walk through this checklist with you, no pressure and no obligation.
Ready to keep production moving?
Start with a quick app or a phone call. We'll tell you exactly what the right program requires. At no charge.
Apply. Fund. Deliver. No obligation.
AI-assistedDepending on live availability, calls may be answered by Mary, our AI Assistant, who takes a message and books a callback. Or email us instead.